38
Participants
Start Date
November 30, 1999
Primary Completion Date
January 31, 2001
Study Completion Date
August 31, 2003
oxaliplatin
paclitaxel
Arthur G. James Cancer Hospital - Ohio State University, Columbus
Michiana Hematology/Oncology P.C., South Bend
Lutheran General Cancer Care Center, Park Ridge
Evanston Northwestern Health Care, Evanston
University of Illinois at Chicago, Chicago
University of Chicago Cancer Research Center, Chicago
Louis A. Weiss Memorial Hospital, Chicago
Oncology/Hematology Associates of Central Illinois, P.C., Peoria
Cancer Care Specialists of Central Illinois, S.C., Decatur
Central Illinois Hematology Oncology Center, Springfield
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
National Cancer Institute (NCI)
NIH
University of Chicago
OTHER